DVL
DVLN · OTC
About DVLN
- Employees
- 10
- Headquarters
- New York City, New York
- Listed
- Aug 3, 1995
- Sector
- Financials
- Industry
- Financial Services
- Website
- dvlninc.com
DVLN key statistics
- Market cap
- 16.80M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 4
- Volume
- 4
- Open price
- $2,800.00
- High today
- $2,800.00
- Low today
- $2,800.00
- 52 Week high
- $3,400.00
- 52 Week low
- $2,500.00
DVL (DVLN) at a glance
As of Oct 13, 2026, DVL (DVLN) shares are priced at $2,800.00, giving the company a market cap of 16.80M and a price-to-earnings ratio of 0.00.
Volume so far is 4 shares, in line with the average of 4 shares a day.
Over the past year DVL has ranged from $2,500.00 to $3,400.00, and now sits 33% of the way up that range.
Similar companies
Companies in the same industry as DVL
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.